In today’s world, effectively communicating scientific discoveries is crucial. As researchers, we must generate knowledge and ensure it reaches and impacts society in meaningful ways. Recently, I’ve been exploring AI tools, such as Google’s NotebookLM, to see how they can enhance the spread and understanding of scientific research. These tools have the potential to make complex information more accessible, and engaging, and even transform how we communicate science. To showcase what’s possible, I’ve used these tools in the podcast I'm sharing here. It’s based on one of our recent publications from Stanford, and it’s a great example of how AI can help bridge the gap between detailed scientific data and public understanding. I’d love to hear your thoughts on AI’s role in transforming scientific communication. How do you think these tools can reshape the way we share science? #ScienceCommunication #AI #ResearchImpact #Stanford #GoogleNotebookLM
Fernando J. García-Marqués’ Post
More Relevant Posts
-
A perspective article on AI and illusions of understanding in scientific research - Uta Schmidt-Straßburger (she/her) #AI #ArtificialInterlligence #Cancer #OncoDaily #Oncology #PerspectiveArticle #ScientificResearch
Uta Schmidt-Straßburger: A perspective article on AI and illusions of understanding in scientific research - OncoDaily
oncodaily.com
-
Internal Communications Senior Director | Executive Communications Business Partner | Creative Storyteller | Designer
At AstraZeneca we are harnessing the power of generative AI to transform drug discovery and development. This technology is enabling us to analyze complex data, optimize clinical trials, and accelerate the creation of life-saving treatments. #GenerativeAI #Oncology #ClinicalInnovation #DataScience
🌐 Transforming patient outcomes with generative AI
astrazeneca.smh.re
-
AI is an incredibly powerful tool for the innovators out there from health to tech to armaments and beyond. One of the most impressive features is its ability to run iterative computations that reduce resource restraints and rapidly progress technological breakthroughs. If you are or know one of these AI innovators, I'd love to talk to you about what you're doing and where you see your work's future impacts. Our team may be able to help you find federal funding to achieve your goals. #AI #tech #armaments
AI is revolutionizing medicine, saving billions of years of research time. Models like AlphaFold 3, developed by Isomorphic Labs and Google DeepMind are being used to design new drugs, develop targeted cancer treatments, build virtual bimolecular worlds – and so much more. More, from Max Jaderberg, Chief AI Officer of Isomorphic Labs: https://goo.gle/4g1sLY6
Max Jaderberg: How AI is saving billions of years of human research time
https://www.ted.com
-
🔬 Check out this recent research from Anindo Saha, MSc, and colleagues investigating the potential of #AI systems as supportive tools for detecting clinically significant #ProstateCancer. 📚 Read More:
AI Systems as Supportive Tools for Detecting Clinically Significant Prostate Cancer | GU Oncology Now
guoncologynow.com
-
🔬 Check out this recent research from Anindo Saha, MSc, and colleagues investigating the potential of #AI systems as supportive tools for detecting clinically significant #ProstateCancer. 📚 Read More:
AI Systems as Supportive Tools for Detecting Clinically Significant Prostate Cancer | GU Oncology Now
guoncologynow.com
-
🔬 Check out this recent research from Anindo Saha, MSc, and colleagues investigating the potential of #AI systems as supportive tools for detecting clinically significant #ProstateCancer. 📚 Read More:
AI Systems as Supportive Tools for Detecting Clinically Significant Prostate Cancer | GU Oncology Now
guoncologynow.com
-
At AstraZeneca, we are harnessing the power of generative #AI to transform drug discovery and development. This technology is enabling us to analyse complex data, optimize clinical trials, and accelerate the creation of life-saving treatments. I’m proud to be part of a team that is pushing the boundaries of science and driving innovation for better patient outcomes. In #NearEast and #Maghreb, we are working hard to collaborate with the different governments specially in #Morocco, #Iraq and #Lebanon where we are able to utilize #ArtificialIntelligence for early detection of different types of cancer including #lungcancer flagging abnormalities, enabling the prioritisation of of a patient's care journey from weeks to days. #GenerativeAI #Oncology #ClinicalInnovation #DataScience #NEMAG #NearEast #Maghreb Tamer Elfishawy George Fouad Omar Hussein Jinane Hajjar Agnar Abou Jaoude Amine Sekhri Ayman Rahhal Abdulkareem Al Dissi Maria Nauss
🌐 Transforming patient outcomes with generative AI
astrazeneca.smh.re
-
𝐀𝐈 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐬𝐢𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: 𝐓𝐡𝐞 𝐆𝐚𝐦𝐞 𝐂𝐡𝐚𝐧𝐠𝐞𝐫𝐬 🌟 The advent of AI is transforming the landscape of medicine, saving billions of years of research time. Cutting-edge models like AlphaFold 3, developed by Isomorphic Labs and Google DeepMind, are leading this charge, offering unprecedented capabilities in drug design, targeted cancer treatments, and even virtual biomolecular worlds. AI is revolutionising medicine by accelerating drug design, improving targeted cancer treatments, and creating virtual biomolecular worlds. What does this mean for the future of healthcare? 🔗 Learn more from Max Jaderberg, Chief AI Officer of Isomorphic Labs #HealthcareInnovation #AIinMedicine #FutureOfHealthcare
AI is revolutionizing medicine, saving billions of years of research time. Models like AlphaFold 3, developed by Isomorphic Labs and Google DeepMind are being used to design new drugs, develop targeted cancer treatments, build virtual bimolecular worlds – and so much more. More, from Max Jaderberg, Chief AI Officer of Isomorphic Labs: https://goo.gle/4g1sLY6
Max Jaderberg: How AI is saving billions of years of human research time
https://www.ted.com
-
Great to see Dave H., our CEO (interim) and CSO, speak to BiotechTV discussing the tightly knit integration of our automated experimentation and generative AI capabilities, and how that drives our oncology focused pipeline forward. Watch this informative interview for insights into upcoming developments, and our learnings as a public technology-driven drug design company: https://lnkd.in/gZXrb8Ub #AI #drugdevelopment #oncology
Exscientia's CEO shares a pipeline overview and learnings from being one of the first AI companies out front and to go public
biotechtv.com
-
Mark your calendars for March 6th, 2PM ET 📅 to join ICF CTO Kyle Tuberson as he hosts the latest FedInsider webinar, joined by Jeff Shilling, CIO, National Cancer Institute (NCI), and Ram C Iyer, CDO, FDA. Use this link to register and hear how these leaders are exploring the latest #datamodernization and #emergingtech trends as they look to drive continued mission success.
Data and AI: Top Trends Shaping Government in 2024 - 1656296
thehub.icf.com
